禁煙補助薬の世界市場レポート 2025年

禁煙補助薬の市場規模は今後数年で急成長が見込まれます。2029年にはCAGR15.7％で799億9,000万米ドルに成長します。予測期間の成長は、研究開発投資、禁煙補助薬の需要拡大、ターゲットを絞ったマーケティングと啓発キャンペーン、薬物療法の進歩に起因すると考えられます。予測期間の主な動向には、個別化治療アプローチ、健康意識の高まり、デジタル治療とアプリ、行動療法の統合、標的マーケティングと教育などがあります。

喫煙中毒の有病率の増加は、今後の禁煙薬市場の成長を促進すると予測されます。喫煙は、マリファナ、ハシシ、タバコなどの植物原料を燃やした蒸気を吸ったり吐いたりしています。禁煙補助薬は、タバコへの欲求を和らげることで喫煙への衝動を抑えるように設計されており、ニコチンの離脱症状を管理する処方薬として使用され、個人の禁煙を効果的に支援します。例えば、2022年7月、カナダの政府機関であるカナダ統計局は、2021年6月と比較してタバコの生産量が5.8％増加したと報告しました。さらに、タバコの総販売本数は2022年5月から1.3％増加し、2022年6月には14億本に達しました。したがって、喫煙中毒の蔓延が禁煙補助薬市場の拡大を牽引しています。

禁煙補助薬市場の成長は、eコマースの台頭によってさらに加速すると予想されます。商品やサービスのオンライン売買を伴うeコマースは、禁煙ソリューションを求める個人に便利なプラットフォームを提供します。禁煙補助薬は、禁煙を目指す人々に控えめで使いやすい選択肢を提供し、オンライン・プラットフォームを通じてますますアクセスしやすくなっています。例えば、2023年8月、米国国勢調査局は、2023年第2四半期の米国小売eコマース売上高が2.1％増加し、2,776億米ドルに達すると推定しました。このeコマース活動の急増は、禁煙補助薬市場の拡大に寄与しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界禁煙補助薬PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、制約）
• 最終用途産業の分析
• 世界の禁煙補助薬市場：成長率分析
• 世界の禁煙補助薬市場の実績：規模と成長, 2019-2024
• 世界の禁煙補助薬市場の予測：規模と成長, 2024-2029, 2034F
• 世界禁煙補助薬総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の禁煙補助薬市場：製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 薬物療法
• 電子タバコ
• ニコチン吸入器
• ニコチン置換療法
• ニコチン舌下錠
• 世界の禁煙補助薬市場薬物による、実績と予測, 2019-2024, 2024-2029F, 2034F
• バレニクリン（チャンティックス）
• ブプロピオン（ザイバン）
• その他の薬物
• 世界の禁煙補助薬市場配布先別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ドラッグストア
• オンライン薬局
• 小売薬局
• 世界の禁煙補助薬市場、薬物療法のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ブプロピオン（ザイバン）
• バレニクリン（チャンティックス）
• 世界の禁煙補助薬市場、電子タバコの種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 使い捨て電子タバコ
• 充電式電子タバコ
• ポッドシステム
• 世界の禁煙補助薬市場ニコチン吸入器の種類別の細分化、実績と予測, 2019-2024, 2024-2029F, 2034F
• 処方箋吸入器
• 市販の吸入器
• 世界の禁煙補助薬市場ニコチン置換療法（NRT）の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ニコチンパッチ
• ニコチンガム
• ニコチントローチ
• 世界の禁煙補助薬市場ニコチン舌下錠の種類別の細分化、実績と予測, 2019-2024, 2024-2029F, 2034F
• 即効性舌下錠
• 徐放性舌下錠

第7章 地域別・国別分析

• 世界の禁煙補助薬市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の禁煙補助薬市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 禁煙補助薬市場：競合情勢
• 禁煙補助薬市場：企業プロファイル
  • 22nd Century Group Overview, Products and Services, Strategy and Financial Analysis
  • Cipla Limited Overview, Products and Services, Strategy and Financial Analysis
  • Dr. Reddy's Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • GSK Plc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• NJOY LLC
• Novartis AG
• Perrigo Company Plc
• Pfizer Inc.
• Philip Morris International
• Glenmark Pharmaceuticals Limited
• Zydus Cadila Healthcare Limited
• Rusan Pharma Ltd.
• BioCorRx Inc.
• CV Sciences Inc.
• Ennaid Therapeutics LLC
• Fertin Pharma A/S
• Gilla Inc.
• Hikma Pharmaceuticals PLC
• Innovus Pharmaceuticals Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 禁煙補助薬市場2029：新たな機会を提供する国
• 禁煙補助薬市場2029：新たな機会を提供するセグメント
• 禁煙補助薬市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Quit smoking drugs are specialized medications used by individuals aiming to quit smoking. These drugs help reduce cravings and alleviate nicotine withdrawal symptoms. They deliver nicotine in alternative forms, such as chewing gum or patches, for a limited period, thus mitigating withdrawal symptoms and the urge to smoke.

The major products within the category of quit-smoking drugs include drug therapy, electronic cigarettes, nicotine inhalers, nicotine replacement therapies, and nicotine sublingual tablets. Drug therapy involves the use of medications to treat or prevent diseases related to smoking cessation. Medications such as Varenicline (Chantix), Bupropion (Zyban), and others are available through various channels, including drug stores, online pharmacies, and retail pharmacies.

The quit smoking drugs market research report is one of a series of new reports from The Business Research Company that provides quit smoking drugs market statistics, including quit smoking drugs industry global market size, regional shares, competitors with a quit smoking drugs market share, detailed quit smoking drugs market segments, market trends and opportunities, and any further data you may need to thrive in the quit smoking drugs industry. This quit smoking drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The quit smoking drugs market size has grown rapidly in recent years. It will grow from $39.26 billion in 2024 to $44.62 billion in 2025 at a compound annual growth rate (CAGR) of 13.7%. The growth in the historic period can be attributed to health awareness campaigns, medical advancements, government initiatives, behavioral therapies integration, consumer attitude shifts.

The quit smoking drugs market size is expected to see rapid growth in the next few years. It will grow to $79.99 billion in 2029 at a compound annual growth rate (CAGR) of 15.7%. The growth in the forecast period can be attributed to research and development investments, growing demand for cessation aids, targeted marketing and awareness campaigns, advancements in pharmacotherapy. Major trends in the forecast period include personalized treatment approaches, increasing health consciousness, digital therapeutics and apps, behavioral therapy integration, targeted marketing and education.

The increasing prevalence of smoking addiction is projected to drive the growth of the quit-smoking drug market in the future. Smoking involves inhaling and exhaling vapors from burning plant materials such as marijuana, hashish, tobacco, and others. Quit-smoking drugs are designed to reduce the urge to smoke by alleviating cravings for tobacco, and they are used as prescription medications to manage nicotine withdrawal symptoms, helping individuals quit smoking effectively. For example, in July 2022, Statistics Canada, a government agency based in Canada, reported a 5.8% increase in cigarette production compared to June 2021. Additionally, the total number of cigarettes sold rose by 1.3% from May 2022, reaching 1.4 billion in June 2022. Therefore, the growing prevalence of smoking addiction is driving the expansion of the quit-smoking drug market.

The growth of the quit-smoking drugs market is expected to be further accelerated by the rise of e-commerce. E-commerce, involving the online buying and selling of goods and services, provides a convenient platform for individuals seeking quit-smoking solutions. Quit-smoking drugs are increasingly accessible through online platforms, offering a discreet and user-friendly option for those aiming to quit smoking. For example, in August 2023, the U.S. Census Bureau estimated a 2.1% increase in U.S. retail e-commerce sales for the second quarter of 2023, reaching $277.6 billion. This surge in e-commerce activities contributes to the expansion of the quit-smoking drugs market.

A key trend in the quit-smoking drugs market is the focus on product innovation by major companies to strengthen their market positions. Notably, Swedish Match AB, a tobacco company based in Sweden, introduced ZYN Tobacco Gold in August 2022. ZYN Tobacco Gold is a nicotine pouch with a sweet tobacco flavor, offering a tobacco-free and smoke-free alternative. This innovative product addresses consumer preferences for reduced-risk alternatives, catering to those who wish to avoid tobacco consumption while still enjoying a nicotine kick in smoke-free environments.

Major companies in the quit smoking drugs market are concentrating on developing new formulations and delivery methods, such as generic tablets, to enhance their market leadership across various regions and gain a competitive advantage. Generic varenicline tablets are non-branded alternatives containing varenicline tartrate, which are bioequivalent to the original branded product and are utilized for smoking cessation therapy. For example, in January 2024, Lupin Limited, a pharmaceutical company based in India, launched new varenicline tablets in the United States, available in strengths of 0.5 mg and 1 mg. These tablets are generic versions of Chantix tablets (0.5 mg and 1 mg) produced by PF Prism C.V. and are designed to aid in smoking cessation treatment. As a partial agonist of the nicotinic acetylcholine receptor, varenicline stimulates the release of dopamine, helping to alleviate withdrawal symptoms and cravings associated with nicotine addiction. This dual mechanism reduces the pleasurable effects of smoking while providing some stimulation to minimize withdrawal symptoms.

In September 2024, Dr. Reddy's Laboratories, an India-based pharmaceutical company, acquired the nicotine replacement therapy business from Haleon plc for $680 million (£500 million). The purpose of this acquisition is to strengthen Dr. Reddy's position in the global consumer healthcare market, particularly by enhancing its over-the-counter (OTC) offerings and expanding its presence in key international markets outside the United States. Haleon plc is a consumer health company based in the UK that specializes in drugs for nicotine addiction.

Major companies operating in the quit smoking drugs market include 22nd Century Group, Cipla Limited, Dr. Reddy's Laboratories, GSK Plc., Johnson & Johnson, NJOY LLC, Novartis AG, Perrigo Company Plc, Pfizer Inc., Philip Morris International, Glenmark Pharmaceuticals Limited, Zydus Cadila Healthcare Limited, Rusan Pharma Ltd., BioCorRx Inc., CV Sciences Inc., Ennaid Therapeutics LLC, Fertin Pharma A/S, Gilla Inc., Hikma Pharmaceuticals PLC, Innovus Pharmaceuticals Inc., IntelGenx Technologies Corp.

North America was the largest region in the quit smoking drugs market in 2024. The regions covered in the quit smoking drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the quit smoking drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The quit-smoking drugs market consists of sales of AXS-05, cytisincline, nadolol, and liraglutide. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Quit Smoking Drugs Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on quit smoking drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for quit smoking drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The quit smoking drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Drug Therapy; E-Cigarettes; Nicotine Inhalers; Nicotine Replacement Therapies; Nicotine Sublingual Tablets
• 2) By Drug: Varenicline (Chantix); Bupropion (Zyban); Other Drugs
• 3) By Distribution: Drug Store; Online Pharmacies; Retail Pharmacies
• Subsegments:
• 1) By Drug Therapy: Bupropion (Zyban); Varenicline (Chantix)
• 2) By E-Cigarettes: Disposable E-Cigarettes; Rechargeable E-Cigarettes; Pod Systems
• 3) By Nicotine Inhalers: Prescription Inhalers; Over-The-Counter Inhalers
• 4) By Nicotine Replacement Therapies (NRT): Nicotine Patches; Nicotine Gum; Nicotine Lozenges
• 5) By Nicotine Sublingual Tablets: Fast-Acting Sublingual Tablets; Extended-Release Sublingual Tablets
• Companies Mentioned: 22nd Century Group; Cipla Limited; Dr. Reddy's Laboratories; GSK Plc.; Johnson & Johnson
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Quit Smoking Drugs Market Characteristics

3. Quit Smoking Drugs Market Trends And Strategies

4. Quit Smoking Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Quit Smoking Drugs Growth Analysis And Strategic Analysis Framework

• 5.1. Global Quit Smoking Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Quit Smoking Drugs Market Growth Rate Analysis
• 5.4. Global Quit Smoking Drugs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Quit Smoking Drugs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Quit Smoking Drugs Total Addressable Market (TAM)

6. Quit Smoking Drugs Market Segmentation

• 6.1. Global Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Drug Therapy
• E-Cigarettes
• Nicotine Inhalers
• Nicotine Replacement Therapies
• Nicotine Sublingual Tablets
• 6.2. Global Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Varenicline (Chantix)
• Bupropion (Zyban)
• Other Drugs
• 6.3. Global Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Drug Store
• Online Pharmacies
• Retail Pharmacies
• 6.4. Global Quit Smoking Drugs Market, Sub-Segmentation Of Drug Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bupropion (Zyban)
• Varenicline (Chantix)
• 6.5. Global Quit Smoking Drugs Market, Sub-Segmentation Of E-Cigarettes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Disposable E-Cigarettes
• Rechargeable E-Cigarettes
• Pod Systems
• 6.6. Global Quit Smoking Drugs Market, Sub-Segmentation Of Nicotine Inhalers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Prescription Inhalers
• Over-The-Counter Inhalers
• 6.7. Global Quit Smoking Drugs Market, Sub-Segmentation Of Nicotine Replacement Therapies (NRT), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Nicotine Patches
• Nicotine Gum
• Nicotine Lozenges
• 6.8. Global Quit Smoking Drugs Market, Sub-Segmentation Of Nicotine Sublingual Tablets, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Fast-Acting Sublingual Tablets
• Extended-Release Sublingual Tablets

7. Quit Smoking Drugs Market Regional And Country Analysis

• 7.1. Global Quit Smoking Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Quit Smoking Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Quit Smoking Drugs Market

• 8.1. Asia-Pacific Quit Smoking Drugs Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Quit Smoking Drugs Market

• 9.1. China Quit Smoking Drugs Market Overview
• 9.2. China Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Quit Smoking Drugs Market

• 10.1. India Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Quit Smoking Drugs Market

• 11.1. Japan Quit Smoking Drugs Market Overview
• 11.2. Japan Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Quit Smoking Drugs Market

• 12.1. Australia Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Quit Smoking Drugs Market

• 13.1. Indonesia Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Quit Smoking Drugs Market

• 14.1. South Korea Quit Smoking Drugs Market Overview
• 14.2. South Korea Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Quit Smoking Drugs Market

• 15.1. Western Europe Quit Smoking Drugs Market Overview
• 15.2. Western Europe Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Quit Smoking Drugs Market

• 16.1. UK Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Quit Smoking Drugs Market

• 17.1. Germany Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Quit Smoking Drugs Market

• 18.1. France Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Quit Smoking Drugs Market

• 19.1. Italy Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Quit Smoking Drugs Market

• 20.1. Spain Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Quit Smoking Drugs Market

• 21.1. Eastern Europe Quit Smoking Drugs Market Overview
• 21.2. Eastern Europe Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Quit Smoking Drugs Market

• 22.1. Russia Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Quit Smoking Drugs Market

• 23.1. North America Quit Smoking Drugs Market Overview
• 23.2. North America Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Quit Smoking Drugs Market

• 24.1. USA Quit Smoking Drugs Market Overview
• 24.2. USA Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Quit Smoking Drugs Market

• 25.1. Canada Quit Smoking Drugs Market Overview
• 25.2. Canada Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Quit Smoking Drugs Market

• 26.1. South America Quit Smoking Drugs Market Overview
• 26.2. South America Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Quit Smoking Drugs Market

• 27.1. Brazil Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Quit Smoking Drugs Market

• 28.1. Middle East Quit Smoking Drugs Market Overview
• 28.2. Middle East Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Quit Smoking Drugs Market

• 29.1. Africa Quit Smoking Drugs Market Overview
• 29.2. Africa Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Quit Smoking Drugs Market Competitive Landscape And Company Profiles

• 30.1. Quit Smoking Drugs Market Competitive Landscape
• 30.2. Quit Smoking Drugs Market Company Profiles
  • 30.2.1. 22nd Century Group Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Cipla Limited Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Dr. Reddy's Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. GSK Plc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis

31. Quit Smoking Drugs Market Other Major And Innovative Companies

• 31.1. NJOY LLC
• 31.2. Novartis AG
• 31.3. Perrigo Company Plc
• 31.4. Pfizer Inc.
• 31.5. Philip Morris International
• 31.6. Glenmark Pharmaceuticals Limited
• 31.7. Zydus Cadila Healthcare Limited
• 31.8. Rusan Pharma Ltd.
• 31.9. BioCorRx Inc.
• 31.10. CV Sciences Inc.
• 31.11. Ennaid Therapeutics LLC
• 31.12. Fertin Pharma A/S
• 31.13. Gilla Inc.
• 31.14. Hikma Pharmaceuticals PLC
• 31.15. Innovus Pharmaceuticals Inc.

32. Global Quit Smoking Drugs Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Quit Smoking Drugs Market

34. Recent Developments In The Quit Smoking Drugs Market

35. Quit Smoking Drugs Market High Potential Countries, Segments and Strategies

• 35.1 Quit Smoking Drugs Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Quit Smoking Drugs Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Quit Smoking Drugs Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer